Kenya plans to introduce Lenacapavir, a long‑acting injectable for HIV prevention, beginning in January 2026 a step expected to strengthen…
Browsing: Lenacapavir
In a groundbreaking development for HIV prevention, a new drug called Yeztugo has been approved as the first-ever twice-yearly injection…
A recent clinical trial has demonstrated success in preventing HIV in adolescent girls and young women. Conducted in Sub-Saharan Africa,…
An annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully completed an important early safety trial. The…
In a significant development for global HIV prevention, the World Health Organization (WHO) has welcomed the latest findings from the…